Legend Biotech Corp ADR (LEGN)

$35.84 -0.99 (-2.69%)
Market Cap 6.77B
Revenue (ttm) 627.24M
Net Income (ttm) -177.03M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -28.22%
Debt to Equity Ratio 0.30
Volume 1,353,200
Avg Vol 1,858,626
Day's Range N/A - N/A
Shares Out 183.76M
Stochastic %K 77%
Beta 0.13
Analysts Strong Sell
Price Target $78.65

Company Profile

Legend Biotech Corporation, through its subsidiaries, operates as a biopharmaceutical company that discovers, develops, manufactures, and commercializes novel cell therapies for oncology and other indications in the United States, China, and Europe. Its lead product candidate is ciltacabtagene autoleucel, or cilta-cel, which is a chimeric antigen receptor (CAR-T) therapy for the treatment of multiple myeloma (MM). The company also has a portfolio of earlier-stage autologous CAR-T product candida...

Industry: Biotechnology
Sector: Healthcare
Phone: 737 317 5050
Address:
2101 Cottontail Lane, Somerset, United States
JFDI
JFDI Jun. 12 at 3:07 PM
The $LEGN of degens are calling.
0 · Reply
topstockalerts
topstockalerts Jun. 12 at 2:21 PM
$LEGN high of day break??🚨🚨
0 · Reply
CrispDry
CrispDry Jun. 12 at 2:01 PM
$LEGN managed to get almost 5% portfolio weight this past week. Something is cooking
0 · Reply
DiamondHandsBTW
DiamondHandsBTW Jun. 12 at 1:59 PM
$LEGN crazy volume lately
0 · Reply
Winning_calls
Winning_calls Jun. 12 at 1:51 PM
$LEGN 🫡🤞
0 · Reply
BiotechBonesaw
BiotechBonesaw Jun. 12 at 6:17 AM
$ALT a couple of years ago the $LEGN CEO told the media openly about Carvykti’s data ahead of one of the major conferences 😆 Buy every dip. Thank me later ✌️
0 · Reply
EPSMomentumStocks
EPSMomentumStocks Jun. 11 at 12:07 PM
These stocks are experiencing exceptionally elevated levels of dollar inflow, indicating strong institutional interest and significant capital allocation activity $MANU $NAMS $MU $SOFI $LEGN #stocks #trading #investing
0 · Reply
DiamondHandsBTW
DiamondHandsBTW Jun. 11 at 12:48 AM
$LEGN if I had to guess I bet they have been approached but there is a gap between the buyers and sellers on valuation hence no deal yet
0 · Reply
jewell69
jewell69 Jun. 11 at 12:21 AM
$LEGN up 8.71% today 6/20/25
0 · Reply
cac772001
cac772001 Jun. 10 at 11:57 PM
$LEGN bought shares and calls under $30. Huge buyout potential here folks!
0 · Reply
Latest News on LEGN
Mizuho's Jared Holz details potential biotech, pharma acquisitions

Jun 4, 2025, 6:10 PM EDT - 12 days ago

Mizuho's Jared Holz details potential biotech, pharma acquisitions

INSM VRNA

Legend Biotech Unveils Groundbreaking 5-Year Survival Data for CARVYKTI® in Multiple Myeloma at 2025 ASCO Annual Meeting

Jun 3, 2025, 10:45 AM EDT - 13 days ago

Legend Biotech Unveils Groundbreaking 5-Year Survival Data for CARVYKTI® in Multiple Myeloma at 2025 ASCO Annual Meeting

Legend Biotech Announces New Oncologic & Hematologic Therapeutic Developments at ASCO, EHA, and ASGCT

May 22, 2025, 5:15 PM EDT - 25 days ago

Legend Biotech Announces New Oncologic & Hematologic Therapeutic Developments at ASCO, EHA, and ASGCT

Legend Biotech Corporation (LEGN) Q1 2025 Earnings Call Transcript

May 13, 2025, 11:15 AM EDT - 4 weeks ago

Legend Biotech Corporation (LEGN) Q1 2025 Earnings Call Transcript

Legend Biotech Reports First Quarter 2025 Results and Recent Highlights

May 13, 2025, 7:00 AM EDT - 4 weeks ago

Legend Biotech Reports First Quarter 2025 Results and Recent Highlights

Cell Therapy Maker Legend Biotech Is An 'Attractive Opportunity' Due To No Material Tariff Exposure: Analyst

Apr 8, 2025, 2:59 PM EDT - 2 months ago

Cell Therapy Maker Legend Biotech Is An 'Attractive Opportunity' Due To No Material Tariff Exposure: Analyst

Legend Biotech Corporation (LEGN) Q4 2024 Earnings Call Transcript

Mar 11, 2025, 12:06 PM EDT - 3 months ago

Legend Biotech Corporation (LEGN) Q4 2024 Earnings Call Transcript

Legend Biotech Reports Fourth Quarter and Full Year 2024 Results and Recent Highlights

Mar 11, 2025, 7:00 AM EDT - 3 months ago

Legend Biotech Reports Fourth Quarter and Full Year 2024 Results and Recent Highlights

Top 5 Commercial Biotech Buyout Candidates: Legend Biotech (No. 4)

Jan 7, 2025, 3:40 PM EST - 5 months ago

Top 5 Commercial Biotech Buyout Candidates: Legend Biotech (No. 4)

Legend Biotech to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Dec 19, 2024, 8:01 AM EST - 6 months ago

Legend Biotech to Present at the 43rd Annual J.P. Morgan Healthcare Conference

CARVYKTI® Significantly Improved Minimal Residual Disease Negativity Compared to Standard of Care for Patients with Relapsed or Refractory Multiple Myeloma

Dec 9, 2024, 7:35 PM EST - 6 months ago

CARVYKTI® Significantly Improved Minimal Residual Disease Negativity Compared to Standard of Care for Patients with Relapsed or Refractory Multiple Myeloma

Legend Biotech: The Story Brightens

Dec 5, 2024, 2:14 PM EST - 6 months ago

Legend Biotech: The Story Brightens

Legend Biotech Corporation (LEGN) Q3 2024 Earnings Call Transcript

Nov 12, 2024, 2:45 PM EST - 7 months ago

Legend Biotech Corporation (LEGN) Q3 2024 Earnings Call Transcript

Legend Biotech to Host Investor Event During the 66th American Society of Hematology (ASH) Annual Meeting and Exposition

Nov 7, 2024, 7:30 AM EST - 7 months ago

Legend Biotech to Host Investor Event During the 66th American Society of Hematology (ASH) Annual Meeting and Exposition

Legend Biotech to Unveil Minimal Residual Disease Data from Landmark CARTITUDE-4 Trial in Multiple Myeloma

Nov 5, 2024, 9:10 AM EST - 7 months ago

Legend Biotech to Unveil Minimal Residual Disease Data from Landmark CARTITUDE-4 Trial in Multiple Myeloma

Legend Biotech Appoints Alan Bash as President of CARVYKTI®

Nov 4, 2024, 7:30 AM EST - 8 months ago

Legend Biotech Appoints Alan Bash as President of CARVYKTI®

Stock Picks From Seeking Alpha's September 2024 New Analysts

Oct 4, 2024, 8:00 AM EDT - 9 months ago

Stock Picks From Seeking Alpha's September 2024 New Analysts

AME CCL CRWD CUK DVN EGO EMR

Legend Biotech to set up new R&D facility in Philadelphia

Oct 3, 2024, 7:41 AM EDT - 9 months ago

Legend Biotech to set up new R&D facility in Philadelphia

Legend Biotech to Establish New, State-of-the-Art Cell Therapy Research and Development Facility in Philadelphia

Oct 3, 2024, 7:30 AM EDT - 9 months ago

Legend Biotech to Establish New, State-of-the-Art Cell Therapy Research and Development Facility in Philadelphia

Johnson & Johnson/ Legend Biotech Partnered Blood Cancer Drug Extends Overall Survival, Support Use In Previously Treated Patients

Sep 30, 2024, 9:47 AM EDT - 9 months ago

Johnson & Johnson/ Legend Biotech Partnered Blood Cancer Drug Extends Overall Survival, Support Use In Previously Treated Patients

JNJ

CARVYKTI® is the First and Only Cell Therapy to Significantly Extend Overall Survival Compared to Standard of Care in Patients with Multiple Myeloma as Early as Second Line

Sep 27, 2024, 4:35 PM EDT - 9 months ago

CARVYKTI® is the First and Only Cell Therapy to Significantly Extend Overall Survival Compared to Standard of Care in Patients with Multiple Myeloma as Early as Second Line

Multiply Labs Announces a Collaboration on Automating Cell Therapy Manufacturing with Legend Biotech

Sep 24, 2024, 9:00 AM EDT - 9 months ago

Multiply Labs Announces a Collaboration on Automating Cell Therapy Manufacturing with Legend Biotech

Legend Biotech: Entering Accelerated Growth Phase, Carvykti Positions Company For Valuation Expansion

Sep 18, 2024, 6:39 AM EDT - 9 months ago

Legend Biotech: Entering Accelerated Growth Phase, Carvykti Positions Company For Valuation Expansion

Legend Biotech to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference

Aug 20, 2024, 8:00 AM EDT - 10 months ago

Legend Biotech to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference

Legend Biotech Corporation (LEGN) Q2 2024 Earnings Call Transcript

Aug 9, 2024, 4:25 PM EDT - 11 months ago

Legend Biotech Corporation (LEGN) Q2 2024 Earnings Call Transcript

Legend Biotech Reports Second Quarter 2024 Results and Recent Highlights

Aug 9, 2024, 7:00 AM EDT - 11 months ago

Legend Biotech Reports Second Quarter 2024 Results and Recent Highlights

Legend Biotech Announces Preliminary Results for the Six-Months Ended June 30, 2024

Jul 26, 2024, 7:00 AM EDT - 11 months ago

Legend Biotech Announces Preliminary Results for the Six-Months Ended June 30, 2024

Legend Biotech to Host Investor Conference Call on Second Quarter 2024 Results

Jul 10, 2024, 8:00 AM EDT - 1 year ago

Legend Biotech to Host Investor Conference Call on Second Quarter 2024 Results

Legend Biotech's Cancer Drug, 'The Most Attractive Product,' Set For Growth: Analyst

Jun 17, 2024, 12:15 PM EDT - 1 year ago

Legend Biotech's Cancer Drug, 'The Most Attractive Product,' Set For Growth: Analyst

Legend Biotech Shares Data on the Earliest Use to Date of CARVYKTI® in the Treatment of Multiple Myeloma and Important Subgroup Analyses at ASCO and EHA

Jun 3, 2024, 4:00 PM EDT - 1 year ago

Legend Biotech Shares Data on the Earliest Use to Date of CARVYKTI® in the Treatment of Multiple Myeloma and Important Subgroup Analyses at ASCO and EHA

Legend Biotech to Participate in the Jefferies Global Healthcare Conference

May 29, 2024, 8:00 AM EDT - 1 year ago

Legend Biotech to Participate in the Jefferies Global Healthcare Conference

Legend Biotech to Highlight Leadership in CAR-T Cell Therapy for Patients with Multiple Myeloma at ASCO and EHA

May 23, 2024, 5:00 PM EDT - 1 year ago

Legend Biotech to Highlight Leadership in CAR-T Cell Therapy for Patients with Multiple Myeloma at ASCO and EHA

Legend Biotech Corporation (LEGN) Q1 2024 Earnings Call Transcript

May 13, 2024, 12:13 PM EDT - 1 year ago

Legend Biotech Corporation (LEGN) Q1 2024 Earnings Call Transcript

Legend Biotech Reports First Quarter 2024 Results and Recent Highlights

May 13, 2024, 7:00 AM EDT - 1 year ago

Legend Biotech Reports First Quarter 2024 Results and Recent Highlights

CARVYKTI® (ciltacabtagene autoleucel) Approved by the European Commission for Second-line Treatment of Patients with Relapsed and Refractory Multiple Myeloma

Apr 22, 2024, 1:05 PM EDT - 1 year ago

CARVYKTI® (ciltacabtagene autoleucel) Approved by the European Commission for Second-line Treatment of Patients with Relapsed and Refractory Multiple Myeloma

Legend Biotech to Host Investor Conference Call on First Quarter 2024 Results

Apr 11, 2024, 8:00 AM EDT - 1 year ago

Legend Biotech to Host Investor Conference Call on First Quarter 2024 Results

Legend Biotech's CARVYKTI® (ciltacabtagene autoleucel) Becomes the First and Only BCMA-Targeted CAR-T Cell Therapy Approved by the FDA for Second-Line Treatment of Multiple Myeloma

Apr 5, 2024, 11:30 PM EDT - 1 year ago

Legend Biotech's CARVYKTI® (ciltacabtagene autoleucel) Becomes the First and Only BCMA-Targeted CAR-T Cell Therapy Approved by the FDA for Second-Line Treatment of Multiple Myeloma

Legend Biotech Announces Publication of Inaugural Environmental, Social and Governance (ESG) Report

Mar 19, 2024, 8:30 AM EDT - 1 year ago

Legend Biotech Announces Publication of Inaugural Environmental, Social and Governance (ESG) Report

CARVYKTI® (ciltacabtagene autoleucel) Receives Recommendation from the U.S. FDA Oncologic Drugs Advisory Committee for Earlier Treatment of Patients with Relapsed/Refractory Multiple Myeloma

Mar 15, 2024, 3:15 PM EDT - 1 year ago

CARVYKTI® (ciltacabtagene autoleucel) Receives Recommendation from the U.S. FDA Oncologic Drugs Advisory Committee for Earlier Treatment of Patients with Relapsed/Refractory Multiple Myeloma

JFDI
JFDI Jun. 12 at 3:07 PM
The $LEGN of degens are calling.
0 · Reply
topstockalerts
topstockalerts Jun. 12 at 2:21 PM
$LEGN high of day break??🚨🚨
0 · Reply
CrispDry
CrispDry Jun. 12 at 2:01 PM
$LEGN managed to get almost 5% portfolio weight this past week. Something is cooking
0 · Reply
DiamondHandsBTW
DiamondHandsBTW Jun. 12 at 1:59 PM
$LEGN crazy volume lately
0 · Reply
Winning_calls
Winning_calls Jun. 12 at 1:51 PM
$LEGN 🫡🤞
0 · Reply
BiotechBonesaw
BiotechBonesaw Jun. 12 at 6:17 AM
$ALT a couple of years ago the $LEGN CEO told the media openly about Carvykti’s data ahead of one of the major conferences 😆 Buy every dip. Thank me later ✌️
0 · Reply
EPSMomentumStocks
EPSMomentumStocks Jun. 11 at 12:07 PM
These stocks are experiencing exceptionally elevated levels of dollar inflow, indicating strong institutional interest and significant capital allocation activity $MANU $NAMS $MU $SOFI $LEGN #stocks #trading #investing
0 · Reply
DiamondHandsBTW
DiamondHandsBTW Jun. 11 at 12:48 AM
$LEGN if I had to guess I bet they have been approached but there is a gap between the buyers and sellers on valuation hence no deal yet
0 · Reply
jewell69
jewell69 Jun. 11 at 12:21 AM
$LEGN up 8.71% today 6/20/25
0 · Reply
cac772001
cac772001 Jun. 10 at 11:57 PM
$LEGN bought shares and calls under $30. Huge buyout potential here folks!
0 · Reply
topstockalerts
topstockalerts Jun. 10 at 7:43 PM
$LEGN following closely👀👀
0 · Reply
OptionRunners
OptionRunners Jun. 10 at 7:01 PM
$LEGN Buyer of the July 18th $40 calls 500 times for $2.00-$2.20. Repeat flow. Strong move today up over 8%
0 · Reply
swingingtech
swingingtech Jun. 10 at 6:52 PM
$EEMA $KE $TME $LEGN https://wallstreetwaves.com/tuesdays-etf-with-unusual-volume-eema/
0 · Reply
Eagley3k
Eagley3k Jun. 10 at 4:14 PM
$LEGN new position. GLTA
0 · Reply
DiamondHandsBTW
DiamondHandsBTW Jun. 10 at 1:58 PM
$LEGN $JNJ pounce on this right now before valuation gets significantly higher… who is on their BD team wake up lol
0 · Reply
CrispDry
CrispDry Jun. 10 at 1:55 PM
$LEGN something seriously brewing
0 · Reply
OptionRunners
OptionRunners Jun. 9 at 5:19 PM
$LEGN Buyer of the December 19th $35 calls 1,050 times for $6.10
0 · Reply
TheDizPlinTrader
TheDizPlinTrader Jun. 9 at 12:53 PM
$LEGN 1H Levels Price: $37.30 Support: $36.18 Resistance: $38.42 Range tightening — watching for breakout signal.
0 · Reply
topstockalerts
topstockalerts Jun. 9 at 12:15 PM
$LEGN setting up nicely..🔥🔥
0 · Reply
Winning_calls
Winning_calls Jun. 9 at 11:57 AM
$LEGN 👋🤞
0 · Reply
briefingcom
briefingcom Jun. 9 at 11:52 AM
Gapping Up: $JBIO +22.4% $MTSR +21.5% $NAMS +10.2% $EVEX +8.8% $LEGN +7.2%
0 · Reply
cac772001
cac772001 Jun. 9 at 10:26 AM
$LEGN buyout coming?
0 · Reply